open access

Vol 13, No 4 (2019)
Review paper
Published online: 2020-01-03
Get Citation

Opioids in clinical practice

Iwona Zaporowska-Stachowiak, Mary-Tiffany Adannia Oduah, Magdalena Celichowska, Gabriela Dziuba, Anna Mikołajczak, Maria Perlińska, Martyna Woźniak, Lidia Gorzelinska, Maciej Sopata
DOI: 10.5603/PMPI.2019.0024
·
Palliat Med Pract 2019;13(4):221-228.

open access

Vol 13, No 4 (2019)
Review articles
Published online: 2020-01-03

Abstract

The treatment of pain improves quality of life. Opioids are commonly prescribed painkillers. The side effects
of opioids depend on the route of administration, dosage, drug metabolism, comorbid diseases and the
patient’s general condition. Despite many beneficial effects, opioids can lead to increased mortality in heart
failure, myocardial infarction, pulmonary oedema, and COPD. This article reviews specific uses of opioid
medications. Opioids induce immunosuppression, and may undergo drug-drug interactions, especially
during polytherapy or polypragmasia.

Abstract

The treatment of pain improves quality of life. Opioids are commonly prescribed painkillers. The side effects
of opioids depend on the route of administration, dosage, drug metabolism, comorbid diseases and the
patient’s general condition. Despite many beneficial effects, opioids can lead to increased mortality in heart
failure, myocardial infarction, pulmonary oedema, and COPD. This article reviews specific uses of opioid
medications. Opioids induce immunosuppression, and may undergo drug-drug interactions, especially
during polytherapy or polypragmasia.

Get Citation

Keywords

adverse effects, analgesia, morphine, opioids, pain management

About this article
Title

Opioids in clinical practice

Journal

Palliative Medicine in Practice

Issue

Vol 13, No 4 (2019)

Article type

Review paper

Pages

221-228

Published online

2020-01-03

DOI

10.5603/PMPI.2019.0024

Bibliographic record

Palliat Med Pract 2019;13(4):221-228.

Keywords

adverse effects
analgesia
morphine
opioids
pain management

Authors

Iwona Zaporowska-Stachowiak
Mary-Tiffany Adannia Oduah
Magdalena Celichowska
Gabriela Dziuba
Anna Mikołajczak
Maria Perlińska
Martyna Woźniak
Lidia Gorzelinska
Maciej Sopata

References (53)
  1. Katzung BG. Basic and Clinical Pharmacology. McGraw-Hill Medical 2012.
  2. Drug Actions: Basic Principles and Therapeutic Aspects, Mutschler. Hartmut .
  3. Liman AG, Gauthier ME. Pharmacology of oioid drugs (basic rinciles). In: Portenoy RK, Bruera E. ed. Toics in alliative care. Oxford University Press, New York 1997.
  4. Coppes OJ, Sang CN. Indications for Opioid Antagonists. Curr Pain Headache Rep. 2017; 21(6): 30.
  5. Leś J, Grzesiak J, Sokół–Kobielska E. Pain therapy Part V. Cancer pain article–4a89b590-2c7c-437d-8951-70aeaa89b807.
  6. Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017; 7: CD012592.
  7. Jamison RN, Mao J. Opioid Analgesics. Mayo Clin Proc. 2015; 90(7): 957–968.
  8. Gommers D, Bakker J. Medications for analgesia and sedation in the intensive care unit: an overview. Crit Care. 2008; 12 Suppl 3: S4.
  9. Rubio-Haro R, Morales-Sarabia J, Ferrer-Gomez C, et al. Regional analgesia techniques for pain management in patients admitted to the intensive care unit. Minerva Anestesiol. 2019; 85(10): 1118–1128.
  10. Jennings AL, Davies AN, Higgins JPT, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002; 57(11): 939–944.
  11. Abernethy AP, Currow DC, Frith P, et al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003; 327(7414): 523–528.
  12. Senderovich H, Yendamuri A. Management of Breathlessness in Palliative Care: Inhalers and Dyspnea-A Literature Review. Rambam Maimonides Med J. 2019; 10(1).
  13. Cohen B, Preuss CV. Opioid Analgesics [Updated 2019 Apr 3]. .
  14. Leppert W, Krajnik M, Wordliczek J. Delivery systems of opioid analgesics for pain relief: a review. Curr Pharm Des. 2013; 19(41): 7271–7293.
  15. Cohen B, Preuss CV. Opioid Analgesics. [Updated 2019 Apr 3]. .
  16. Miyazaki T, Satou S, Ohno T, et al. Topical morphine gel for pain management in head and neck cancer patients. Auris Nasus Larynx. 2014; 41(5): 496–498.
  17. Giannopoulos G, Deftereos S, Kolokathis F, et al. P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison? Circ Cardiovasc Interv. 2016; 9(9).
  18. Anderson IB, Kearney TE. Use of methadone. West J Med. 2000; 172(1): 43–46.
  19. Cavallari LH, Jeong H, Bress A. Role of cytochrome P450 genotype in the steps toward personalized drug therapy. Pharmgenomics Pers Med. 2011; 4: 123–136.
  20. Dickman A. Drugs in Palliative Care. Oxford Medicine Online. 2012.
  21. Jamison RN, Mao J. Opioid Analgesics. Mayo Clin Proc. 2015; 90(7): 957–968.
  22. Dumas EO, Pollack GM. Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J. 2008; 10(4): 537–551.
  23. Meine TJ, Roe MT, Chen AY, et al. CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149(6): 1043–1049.
  24. Kao D, Bucher Bartelson B, Khatri V, et al. Trends in reporting methadone-associated cardiac arrhythmia, 1997-2011: an analysis of registry data. Ann Intern Med. 2013; 158(10): 735–740.
  25. Brown R, Kraus C, Fleming M, et al. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004; 80(949): 654–659.
  26. Mattia C. Coluzzi, F. A look inside the association codeine–paracetamol: clinical pharmacology supports analgesic efficacy. Eur Rev Medical Pharmacological Sciences 2015; 19: 507–516. PMID. ; 25720726.
  27. Leppert W. Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain. Curr Drug Metab. 2010; 11(6): 494–506.
  28. Leppert W, Majkowicz M. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract. 2010; 64(12): 1681–1687.
  29. Robertson JR, Raab GM, Bruce M, et al. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial. Addiction. 2006; 101(12): 1752–1759.
  30. Leppert W, Majkowicz M. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain. Int J Clin Pract. 2010; 64(12): 1681–1687.
  31. Robertson JR, Raab GM, Bruce M, et al. Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial. Addiction. 2006; 101(12): 1752–1759.
  32. Edwards JE, McQuay HJ, Moore RA. Single dose dihydrocodeine for acute postoperative pain. Cochrane Database Syst Rev. 2000(4): CD002760.
  33. Bolser DC. Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl): 238S–249S.
  34. Finnerup N, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology. 2015; 14(2): 162–173.
  35. de Alencar Neto JN. Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review. Cureus. 2018; 10(1): e2114.
  36. Peacock WF, Hollander JE, Diercks DB, et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency Medicine Journal. 2008; 25(4): 205–209.
  37. Miró Ò, Gil V, Peacock WF. Morphine in acute heart failure: good in relieving symptoms, bad in improving outcomes. J Thorac Dis. 2017; 9(9): E871–E874.
  38. Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not analgesia. Br J Anaesth. 2006; 96: 627–632.
  39. Bonin M, Mewton N, Roubille F, et al. CIRCUS Study Investigators. Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2018; 7(4).
  40. Kubica J, Adamski P, Ostrowska M, et al. Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial. Eur Heart J. 2016; 37(3): 245–252.
  41. Meine TJ, Roe MT, Chen AY, et al. CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J. 2005; 149(6): 1043–1049.
  42. Hobl EL, Stimpfl T, Ebner J, et al. Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol. 2014; 63(7): 630–635.
  43. Iakobishvili Z, Cohen E, Garty M, et al. Heart Failure Survey in Isarel (HFSIS) Investigators. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care. 2011; 13(2): 76–80.
  44. Dominguez-Rodriguez A, Abreu-Gonzalez P. A critical appraisal of the morphine in the acute pulmonary edema: real or real uncertain? J Thorac Dis. 2017; 9(7): 1802–1805.
  45. Sosnowski MA. Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema. Emerg Med Australas. 2008; 20(5): 384–390.
  46. Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol. 2016; 81(1): 161–170.
  47. Abdallah SJ, Wilkinson-Maitland C, Saad N, et al. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J. 2017; 50(4).
  48. Caraceni A, Davies A, Poulain P, et al. Lancet Oncol. 2012; 13: 58–68.
  49. Corli O, Forliani I, Roberto A, et al. Ann Oncol. 2016; 27: 1107–1115.
  50. Rigamonti CI, Santini D, Maranzano E, et al. Ann Oncol. 2012; 23(Suppl 7): 139–154.
  51. Misiołek H, Zajączkowska R, Daszkiewicz A. Postoperative pain management — 2018. Anaesthesiol Intensive Ther. 2018.
  52. Smith J, Owen E, Earis J, et al. Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2006; 117(4): 831–835.
  53. Bolser DC, Davenport PW. Codeine and cough: an ineffective gold standard. Curr Opin Allergy Clin Immunol. 2007; 7(1): 32–36.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Medycyna Paliatywna w Praktyce dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl